(Reuters) -Moderna has won a case at the European Patent Office against Pfizer and BioNTech in a dispute over its COVID-19 vaccine, the company said on Friday. Moderna said that the European Patent Office had decided to maintain the validity of one of the company’s key patents currently asserted against Pfizer and BioNTech in various […]
(Reuters) – BioNTech said on Monday the U.S. National Institutes of Health has sent a notice to the German company regarding default on the payment of royalties and other amounts related to its COVID-19 vaccine. BioNTech, which partnered with U.S. pharma giant Pfizer for its COVID-19 vaccine, however, said it disagreed with the positions being […]
BioNTech (BNTX) stock tumbled to its lowest point in three years Wednesday after the Covid vaccine maker reported light fourth-quarter sales and profit, and delivered lackluster 2024 guidance. X The Covid vaccine, developed with Pfizer (PFE), is BioNTech’s only commercial product. In the fourth quarter, Comirnaty sales plummeted 65% to just north of $1.6 billion […]